Welcome Megan, Rob! Congrats to Marius!
/Archive from July 2014
Welcome Megan Berry and Rob Wilson as summer research interns! Megan is working with the Myc team and Rob is working on CETSA assays in an effort to demonstrate target engagement in cells for a Class II HDAC inhibitor.
Congratulations to Marius Pop on his new paper describing our efforts to target the oncoprotein ETV1 in Molecular Cancer Therapeutics! This collaborative project involving investigators at the Koch Institute, DFCI and the Broad Institute provided preliminary results for a new project focused on targeting deregulated transcription factors in prostate cancer. This project is part of the Transcend Partnership between KI and Janssen Pharmaceuticals, Inc.